BIOMARIN PHARMACEUTICAL INC shareholders Q2 2022

BIOMARIN PHARMACEUTICAL INC's ticker is BMRN and the CUSIP is 09061G101. A total of 524 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2022. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

BIOMARIN PHARMACEUTICAL INC shareholders Q2 2022
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,061,373$170,82614.89%
DSC Advisors, L.P. 82,500$6,8376.83%
HealthCor Management, L.P. 740,948$61,4026.17%
Camber Capital Management LP 1,500,000$124,3055.39%
Avoro Capital Advisors LLC 3,284,000$272,1455.38%
Senator Investment Group LP 850,000$70,4405.04%
NAN FUNG TRINITY (HK) Ltd 217,014$17,9835.00%
BRIDGER MANAGEMENT, LLC 207,800$17,2203.88%
Baker Brothers Advisors 7,620,494$631,5103.58%
Deep Track Capital, LP 654,365$54,2273.56%
PFM Health Sciences, LP 839,371$69,5592.65%
Orbimed Advisors 1,699,710$140,8552.55%
SECTORAL ASSET MANAGEMENT INC 141,730$11,7452.37%
Sivik Global Healthcare LLC 47,500$3,9362.24%
SeaTown Holdings Pte. Ltd. 122,175$10,1252.20%
Integral Health Asset Management, LLC 126,286$10,4652.15%
Sofinnova Investments, Inc. 301,605$24,9942.08%
SECTOR GAMMA AS 105,259$8,7231.95%
VIKING GLOBAL INVESTORS LP 5,052,593$418,7081.92%
Motley Fool Wealth Management, LLC 348,989$28,9211.82%

External links

This page lists BIOMARIN PHARMACEUTICAL INC's shareholders in Q2 2022. To view BIOMARIN PHARMACEUTICAL INC's shareholder history, click here.